Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Propofol TCI (Target Controlled Infusion)Administered by Gastroenterologists During Endoscopy in Moderate Sedation: a Randomized Double Blind Controlled Study

NCT01941888 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.

NCT NCT01941888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01941888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Propofol TCI (Target Controlled Infusion)Administered by Gastroenterologists During Endoscopy in Moderate Sedation: a Randomized Double Blind Controlled Study
Lead sponsor
Ospedale San Raffaele
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2012
Completion date
March 31, 2013
Enrollment
140 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal endoscopy, moderate sedation, propofol, target controlled infusion